显微手术治疗胼胝体前部胶质瘤30例报告

Microneurosurglcal Treatment of Gliomas in Anterior corpuscallosum(30 cases)

目的：探讨胼胝体前部胶质瘤的临床特点、应用显微手术切除的可行性及其预后。方法：对我院1998年1月至2004年6月收治的30例经手术及病理证实的胼胝体前部胶质瘤患者进行回顾性分析。结果：手术全切除18例，次全切除9例，部分切除3例。术后无1例死亡，4例术后出现短暂性失语和反应迟钝，3例术后癫痫小发作，2例术后出现短暂性右上肢无力，21例术后恢复良好。22例随访6个月至6年，平均生存期18个月。结论：胼胝体前部胶质瘤的治疗以手术切除为首选，对于大部分病例，全切或次全切除肿瘤取得良好的临床效果是完全可能的。经胼胝体前部人路是治疗该区肿瘤的一个安全可行的选择。

Objective： To study the clinical characteristics, microsurgical feasibility and prognosis of gliomas in the anterior corpus callosum. Methods： 30 cases treated with microsurgical technologies for gliomas in anterior corpus callosum were analyzed retrospectively in our hospital from January 1998 to June 2004. Results： Total removal was achieved in 18 cases, subtotal removal in 9 cases and biopsy in 3 cases. There were no operative deaths. The fine postoperative recovery resulted in 21 cases, but there were transient aphasia and reaction dullness in 4 cases, minor epilepsy in 3 cases and right upper extremities asthenia in 2 cases. The median survival time was 18 weeks in 22 cases followed up from six months to six years after operation. Conclusion： Microneurosurgical removal is the primary choice to treat gliomas in the anterior corpus callosum and anterior transcallosal approach is a safe and feasible alternative in managerrtent of tumors in this region.